Literature DB >> 12554896

Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

K Amin1, A Ekberg-Jansson, C-G Löfdahl, P Venge.   

Abstract

BACKGROUND: A study was undertaken to investigate the relationship between inflammatory cells and structural changes in the mucosa of the airways in an epidemiological sample of a group of asymptomatic smokers (smokers who had never sought medical attention for respiratory problems) and in non-smoking subjects.
METHODS: Bronchial biopsy specimens were taken from 29 smokers and 16 never smokers and stained with monoclonal antibodies HNL, EPO, AA1, CD68 in order to identify neutrophils, eosinophils, mast cells, and macrophages, respectively. The biopsy specimens were also stained with monoclonal antibodies to the cytokines interleukin (IL)-1beta and IL-8. Structural changes were identified by staining the biopsy specimens with antibodies to tenascin and laminin and by evaluating the condition of the epithelial layer.
RESULTS: The numbers of all inflammatory cells and of cytokine staining cells were significantly increased in smokers. The thickness of the tenascin and laminin layers was increased in the smoking group and the integrity of the epithelial layer was significantly reduced. In smokers the epithelial integrity was negatively correlated with the number of eosinophils and macrophages. The thickness of the tenascin and laminin layers was positively correlated with AA1 and EPO positive cells only.
CONCLUSION: High numbers of inflammatory cells are present in the bronchial mucosa of asymptomatic smokers which have a clear relationship with the impaired epithelial integrity. The increased thickness of the laminin and tenascin layers in these subjects was strongly related to the presence of eosinophils and mast cells, suggesting a role for these cells in tissue remodelling of the airways of smokers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554896      PMCID: PMC1746573          DOI: 10.1136/thorax.58.2.135

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  39 in total

1.  Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation.

Authors:  M Saetta; G Turato; S Baraldo; A Zanin; F Braccioni; C E Mapp; P Maestrelli; G Cavallesco; A Papi; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

2.  A comparison of the expression of lymphocyte activation markers in blood, bronchial biopsies and bronchoalveolar lavage: evidence for an enrichment of activated T lymphocytes in the bronchoalveolar space.

Authors:  A Ekberg-Jansson; E Arvå; O Nilsson; C G Löfdahl; B Andersson
Journal:  Respir Med       Date:  1999-08       Impact factor: 3.415

Review 3.  Cellular and structural bases of chronic obstructive pulmonary disease.

Authors:  M Saetta; G Turato; P Maestrelli; C E Mapp; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

4.  Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

Authors:  Shelley R Salpeter; Thomas M Ormiston; Edwin E Salpeter
Journal:  Ann Intern Med       Date:  2002-11-05       Impact factor: 25.391

5.  Measurement of closing volume with the single breath nitrogen method.

Authors:  H Oxhøj; B Bake
Journal:  Scand J Respir Dis       Date:  1974

6.  Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.

Authors:  A Ekberg-Jansson; B Andersson; B Bake; M Boijsen; I Enanden; A Rosengren; B E Skoogh; U Tylén; P Venge; C G Löfdahl
Journal:  Respir Med       Date:  2001-05       Impact factor: 3.415

7.  Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group.

Authors:  K Amin; D Lúdvíksdóttir; C Janson; O Nettelbladt; E Björnsson; G M Roomans; G Boman; L Sevéus; P Venge
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

8.  Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease.

Authors:  B E Lams; A R Sousa; P J Rees; T H Lee
Journal:  Eur Respir J       Date:  2000-03       Impact factor: 16.671

9.  Effects of TNF-alpha, IFN-gamma and IL-beta on normal human bronchial epithelial cells.

Authors:  C Kampf; A J Relova; S Sandler; G M Roomans
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

Review 10.  Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation?

Authors:  M G Traber; A van der Vliet; A Z Reznick; C E Cross
Journal:  Clin Chest Med       Date:  2000-03       Impact factor: 2.878

View more
  18 in total

1.  Differential distribution of inflammatory cells in large and small airways in smokers.

Authors:  Salvatore Battaglia; Thais Mauad; Annemarie M van Schadewijk; Antonia M Vignola; Klaus F Rabe; Vincenzo Bellia; Peter J Sterk; Pieter S Hiemstra
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

2.  Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking.

Authors:  Adriana Heguy; Timothy P O'Connor; Karsta Luettich; Stefan Worgall; Adam Cieciuch; Ben-Gary Harvey; Neil R Hackett; Ronald G Crystal
Journal:  J Mol Med (Berl)       Date:  2006-03-07       Impact factor: 4.599

Review 3.  Impact of smoking on inflammation: overview of molecular mechanisms.

Authors:  R B Gonçalves; R D Coletta; K G Silvério; L Benevides; M Z Casati; J S da Silva; F H Nociti
Journal:  Inflamm Res       Date:  2011-02-05       Impact factor: 4.575

4.  Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients.

Authors:  Mariana Muñoz-Esquerre; Daniel Huertas; Ignacio Escobar; Marta López-Sánchez; Rosa Penín; Victor Peinado; Joan Albert Barberà; María Molina-Molina; Frederic Manresa; Jordi Dorca; Salud Santos
Journal:  Lung       Date:  2015-03-21       Impact factor: 2.584

Review 5.  Pathogenesis of inflammation and repair in advanced COPD.

Authors:  William D Cornwell; Victor Kim; Changcheng Song; Thomas J Rogers
Journal:  Semin Respir Crit Care Med       Date:  2010-05-21       Impact factor: 3.119

6.  Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers.

Authors:  Izolde Bouloukaki; Maria Tsoumakidou; Constantine I Vardavas; Ioanna Mitrouska; Eleni Koutala; Nikolaos M Siafakas; Sophia E Schiza; Nikos Tzanakis
Journal:  Mediators Inflamm       Date:  2010-02-23       Impact factor: 4.711

7.  Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study.

Authors:  Ulla-Britt Jönsson; Lena Douhan Håkansson; Rain Jõgi; Christer Janson; Per Venge
Journal:  BMC Pulm Med       Date:  2010-06-09       Impact factor: 3.317

8.  Airway inflammation in aluminium potroom asthma.

Authors:  T Sjåheim; T S Halstensen; M B Lund; Ø Bjørtuft; P A Drabløs; D Malterud; J Kongerud
Journal:  Occup Environ Med       Date:  2004-09       Impact factor: 4.402

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.